Immunotherapy in breast cancer: current landscape and emerging trends
Abstract Breast cancer remains one of the most prevalent malignancies worldwide, underscoring an urgent need for innovative therapeutic strategies. Immunotherapy has emerged as a transformative frontier in this context. In triple-negative breast cancer (TNBC), the combination of immunotherapy based...
Saved in:
| Main Authors: | Ran Ran, Xi Chen, Jin Yang, Binghe Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00667-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy for triple-negative breast cancer: current trends and future prospects
by: Amina Essalihi, et al.
Published: (2025-06-01) -
Current and future immunotherapy for breast cancer
by: Natalie K. Heater, et al.
Published: (2024-12-01) -
TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives
by: Zhuohong Yan, et al.
Published: (2025-05-01) -
Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
by: Ting Zhang, et al.
Published: (2025-06-01) -
Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
by: Hua Lu, et al.
Published: (2025-06-01)